Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (8): 808-812.doi: 10.3969/j.issn.1000-6621.2021.08.010
• Original Articles • Previous Articles Next Articles
WANG Li, XIONG Kun-long, ZHU Chang-tai(), FAN Lin()
Received:
2021-04-22
Online:
2021-08-10
Published:
2021-07-30
Contact:
WANG Li,ZHU Chang-tai,FAN Lin
E-mail:zct101@163.com;fanlinsj@163.com
WANG Li, XIONG Kun-long, ZHU Chang-tai, FAN Lin. T lymphocyte exhaustion on the expression of immune effect in patients with multidrug-resistant pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 808-812. doi: 10.3969/j.issn.1000-6621.2021.08.010
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.08.010
抑制性受体 | MDR-PTB组 | DS-PTB组 | HD组 | Z值 | P值a | Z值 | P值b | Z值 | P值c |
---|---|---|---|---|---|---|---|---|---|
CD4-PD-1 | 24.50(21.58,26.00) | 14.50(11.90,20.00) | 13.10(11.80,17.80) | -4.009 | <0.01 | -4.159 | <0.01 | -0.410 | 0.535 |
CD8-PD-1 | 19.95(16.10,21.65) | 13.20(8.61,18.23) | 12.55(9.61,18.18) | -3.027 | 0.001 | -3.284 | 0.001 | -0.165 | 0.874 |
CD4-Tim-3 | 3.75(3.20,4.68) | 1.12(0.71,3.36) | 0.67(0.46,2.41) | -3.565 | 0.001 | -3.967 | <0.01 | -1.151 | 0.255 |
CD8-Tim-3 | 12.65(10.65,14.10) | 3.59(2.10,7.52) | 3.78(2.35,6.55) | -5.568 | <0.01 | -3.261 | 0.001 | -0.084 | 0.941 |
CD4-Lag-3 | 2.27(0.66,4.43) | 1.11(0.65,1.91) | 1.11(0.81,1.55) | -1.076 | 0.293 | -1.304 | 0.196 | -0.020 | 0.988 |
CD8-Lag-3 | 20.90(16.00,34.80) | 25.05(18.05,32.35) | 24.15(16.75,29.68) | -0.492 | 0.446 | 0.310 | 0.883 | -0.583 | 0.340 |
免疫效应因子 | MDR-PTB组 | DS-PTB组 | HD组 | Z值 | P值a | Z值 | P值b | Z值 | P值c |
---|---|---|---|---|---|---|---|---|---|
CD4-IL-2 | 1.30(0.73,2.71) | 1.51(0.83,2.10) | 0.67(0.44,1.10) | -0.460 | 0.654 | -2.670 | 0.005 | -3.788 | <0.01 |
CD8-IL-2 | 2.27(1.03,3.11) | 2.12(1.55,3.04) | 0.59(0.39,0.91) | -0.932 | 0.358 | -3.917 | <0.01 | -5.285 | <0.01 |
CD4-IFN-γ | 0.45(0.30,1.65) | 0.92(0.59,2.02) | 0.65(0.38,0.82) | -1.499 | 0.136 | -0.349 | 0.736 | -2.337 | 0.019 |
CD8-IFN-γ | 1.16(0.53,2.03) | 1.80(0.97,3.04) | 0.69(0.35,0.91) | -1.670 | 0.096 | -1.988 | 0.047 | -4.455 | <0.01 |
CD4-TNF-α | 0.41(0.28,0.82) | 0.83(0.67,1.22) | 0.44(0.28,0.71) | -2.919 | 0.003 | -0.179 | 0.862 | -3.903 | <0.01 |
CD8-TNF-α | 1.23(0.57,1.44) | 0.84(0.42,1.22) | 0.61(0.40,1.00) | -1.203 | 0.231 | -1.444 | 0.153 | -0.673 | 0.508 |
[1] | 吴碧彤, 谭守勇, 蔡杏珊, 等. 耐药结核性胸膜炎胸液生化及临床特点. 广东医学, 2017, 38(17):2617-2620. doi: 10.3969/j.issn.1001-9448.2017.17.009. |
[2] | 蒋龄周. 贞芪扶正颗粒联合抗结核药治疗肺结核临床疗效及对T淋巴细胞亚群的影响. 中医药信息, 2017, 34(5):104-107. doi: 10.3969/j.issn.1002-2406.2017.05.030. |
[3] |
Brighenti S, Andersson J. Local immune responses in human tuberculosis: learning from the site of infection. J Infect Dis, 2012, 205Suppl 2:S316-324. doi: 10.1093/infdis/jis043.
doi: 10.1093/infdis/jis043 URL |
[4] |
Wherry EJ. T cell exhaustion. Nature Immunology, 2011, 12(6):492-499. doi: 10.1038/ni.2035.
URL pmid: 21739672 |
[5] |
Day CL, Abrahams DA, Lerumo L, et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol, 2011, 187(5):2222-2232. doi: 10.4049/jimmunol.1101122.
doi: 10.4049/jimmunol.1101122 URL |
[6] |
Lee JS, Song CH, Kim CH, et al. Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol, 2002, 128(3):516-524. doi: 10.1046/j.1365-2249.2002.01858.x.
URL pmid: 12067307 |
[7] |
Geffner L, Yokobori N, Basile J, et al. Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains. Infect Immun, 2009, 77(11):5025-5034. doi: 10.1128/IAI.00224-09.
doi: 10.1128/IAI.00224-09 URL pmid: 19720756 |
[8] | Churina EG, Urazova OI, Novitskiy VV. The role of foxp3-expressing regulatory T cells and T helpers in immunopathogenesis of multidrug resistant pulmonary tuberculosis. Tuberc Res Treat, 2012, 2012:931291. doi: 10.1155/2012/931291. |
[9] |
Pauken KE, Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol, 2015, 36(4):265-276. doi: 10.1016/j.it.2015.02.008.
doi: 10.1016/j.it.2015.02.008 URL |
[10] |
Khan N, Vidyarthi A, Amir M, et al. T-cell exhaustion in tuberculosis: pitfalls and prospects. Crit Rev Microbiol, 2017, 43(2):133-141. doi: 10.1080/1040841X.2016.1185603.
doi: 10.1080/1040841X.2016.1185603 URL |
[11] |
Day CL, Moshi ND, Abrahams DA, et al. Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment. PLoS One, 2014, 9(4):e94949. doi: 10.1371/journal.pone.0094949.
doi: 10.1371/journal.pone.0094949 URL |
[12] |
Sakai S, Kawamura I, Okazaki T, et al. PD-1-PD-L1 pathway impairs Th1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin. Int Immunol, 2010, 22(12):915-925. doi: 10.1093/intimm/dxq446.
doi: 10.1093/intimm/dxq446 URL |
[13] |
Jayaraman P, Jacques MK, Zhu C, et al. TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection. PLoS Pathog, 2016, 12(3):e1005490. doi: 10.1371/journal.ppat.1005490.
doi: 10.1371/journal.ppat.1005490 URL |
[14] | 任军, 黄红艳. 靶向免疫检查点的肿瘤免疫治疗现状与趋势. 中国肿瘤临床, 2014, 41(7):415-419. doi: 10.3969/j.issn.1000-8179.20140359. |
[15] |
Otano I, Escors D, Schurich A, et al. Molecular Recalibration of PD-1+Antigen- Specific T Cells from Blood and Liver. Mol Ther, 2018, 26(11):2553-2566. doi: 10.1016/j.ymthe.2018.08.013.
doi: 10.1016/j.ymthe.2018.08.013 URL |
[16] |
Nebbia G, Peppa D, Schurich A, et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One, 2012, 7(10):e47648. doi: 10.1371/journal.pone.0047648.
doi: 10.1371/journal.pone.0047648 URL |
[17] | 陈少华, 查显丰, 李扬秋. TIM-3、LAG-3和BTLA介导的血液肿瘤免疫耐受及其逆转研究. 中国实验血液学杂志, 2016, 24(5):1594-1597. doi: 10.7534/j.issn.1009-2137.2016.05.056. |
[18] |
Torphy RJ, Schulick RD, Zhu Y. Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy. Int J Mol Sci, 2017, 18(12):2642. doi: 10.3390/ijms18122642.
doi: 10.3390/ijms18122642 URL |
[19] |
Tan Q, Xie WP, Min R, et al. Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis, 2012, 31(6):1233-1242. doi: 10.1007/s10096-011-1434-4.
doi: 10.1007/s10096-011-1434-4 URL |
[20] |
Turner J, Frank AA, Brooks JV, et al. Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology. Immunology, 2001, 102(2):248-253. doi: 10.1046/j.1365-2567.2001.01161.x.
URL pmid: 11260331 |
[21] |
Crawford A, Angelosanto J, Kao C, et al. Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection. Immunity, 2014, 40(2):289-302. doi: 10.1016/j.immuni.2014.01.005.
doi: 10.1016/j.immuni.2014.01.005 URL pmid: 24530057 |
[22] | Fan L, Xiao H, Mai G, et al. Impaired M.tuberculosis Antigen-Specific IFN-gamma Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary Tuberculosis. PLoS One, 2015, 10(5):e127087. doi: 10.1371/journal.pone.0127087. |
[23] |
Takashima T, Ueta C, Tsuyuguchi I, et al. Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect Immun, 1990, 58(10):3286-3292. doi: 10.1128/IAI.58.10.3286-3292.1990.
URL pmid: 2205576 |
[1] | LIU Guang-tian, DING Xiao-yan, LEI Juan, LIU Tao, PAN Li, TIAN Xiao-mei, CHEN Lin-lin, WANG Xiao-lin. Evaluation of medical expenses and financing models of pulmonary tuberculosis patients in three districts of Yinchuan City in 2016 and 2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 766-771. |
[2] | WANG Quan, MA Rui-ying, YANG Ting, ZHANG Ya-li, XU Miao, SA Yu-ling, CHEN Qing-bo. Application value of thermostatic microfluidic system in detection and identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 817-820. |
[3] | YANG Xiao-li, HE Bing, WANG Jiao-lei, ZHANG Yun-yun, ZHANG Chun-xia, LI Yue, LI Jian-jun, SHI Wen-tao. Diagnostic value of GeneXpert MTB/RIF in detecting patients with coal workers’ pneumoconiosis complicated with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 821-825. |
[4] | AI Ya-juan, HAN Xu. Effect evaluation of rapid rehabilitation based systematic model in patients with sleep disorder after thoracolumbar tuberculosis surgery [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 452-456. |
[5] | CHEN Ke-fan, XIONG Yu-jiao, JIAO Jia-huan, YUAN Shu-sheng. Value of CD44 and related cytokine levels in the diagnosis and prognosis evaluation of active pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 513-515. |
[6] | YU Shan, LI Zhi-ming, XU Chun-xia, WANG Tao. Analysis of risk factors associated with false negative results of interferon-gamma release assays on peripheral blood from tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 346-351. |
[7] | LIU Ting*, WANG Liang, YANG Mei. The study on the anti-tuberculosis activity of polymorphonuclear cell from peripheral blood of patients with multidrug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 352-356. |
[8] | DUAN Hui-juan, CHU Hong-qian, KONG Cheng-cheng, DAI Guang-ming, CAO Ting-ming, SUN Zhao-gang. Evaluation of the effect of skin reaction on 11 Mycobacterium tuberculosis antigens [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 255-260. |
[9] | KUANG Hao-bin, XIE Yu-hong, FENG Zhi-yu, QIN Hong-juan, LIAO Ya-yi, WANG Min, ZHANG Hong, YUANG Yuan, WU Di, CHEN Ze-ying, TAN Shou-yong. Analysis on the effect of management strategies for multidrug-resistant tuberculosis in Guangzhou from 2014-2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 113-118. |
[10] | LU Ni-hong, SUN Ya-ping, JIN Yuan, XIA Jia-wei, YANG Yong-rui. Application value of ESAT-6 combined with MMP-9 in assessing the severity of tuberculosis destroyed lung [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 139-142. |
[11] | CUI Xiao-jing, WEI Dong, WANG Chun-lei, CAO Bin. Value of molecular diagnosis and liquid culture methods in improving the pathogenic diagnosis of pulmonary tuberculosis in general hospitals [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 143-146. |
[12] | LIU Zhi-bin, WU Min, WU Xiao-cui, HAN Min, XIAO He-ping, ZHANG Qing. The value of PCR-reverse dot blot hybridization in detecting the drug resistance of Mycobacterium tuberculosis in sputum specimens of retreatment smear-positive pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 47-51. |
[13] | ZHANG Kai, TAO Li-feng, WEI Fen, DU Wei-xin, QIU Jing-jing, CHEN Wei, CHEN Bao-wen, ZHU Yin-meng, CHENG Xing, SU Cheng, ZHONG Zai-xin, LU Jin-biao, PU Jiang. Immune characteristics and preclinical animal safety studies of recombinant Mycobacterium tuberculosis fusion protein(EC) [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 807-813. |
[14] | CHEN Feng-fang, MA Jun, HUANG Jin, YIN Hong-yun, SHA Wei, YANG Guang-hong, FENG Yong-hong. Preliminary study on establishing the diagnostic model for smear negative tuberculosis and stage Ⅰ/Ⅱ sarcoidosis with hilar/mediastinal lymphadenopathy and positive T-SPOT.TB results [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 832-837. |
[15] | DUAN Li-ming, DING Chao, LIU Yu-gang, WEI Lin, GU Zhen-ning. Application value of video-assisted thoracoscopic surgery in the treatment of chronic tuberculous empyema [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 850-853. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||